drugset / Trial / NCT01000922
A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro
Non-randomizedCrossoverOpen-labelTreatment
Summary
Evaluation of post-prandial blood glucose excursions after a standardized meal and pre meal injections of individual doses of the study insulins.
Timeline
- Start
- 2006-06
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Subcutaneous |
| Subject | Insulin Lispro | Protein / enzyme biologic | — | Subcutaneous |
| Subject | VIAject™ | Protein / enzyme biologic | 50 % | Subcutaneous |
| Background | insulin glargine | Protein / enzyme biologic | — | Subcutaneous |